X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3796) 3796
Publication (478) 478
Book Review (88) 88
Book / eBook (38) 38
Book Chapter (21) 21
Conference Proceeding (4) 4
Dissertation (3) 3
Magazine Article (1) 1
Newsletter (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (2201) 2201
animals (2006) 2006
humans (1974) 1974
index medicus (1659) 1659
rats (1201) 1201
pharmacology & pharmacy (1147) 1147
female (1100) 1100
neurosciences (994) 994
adrenergic uptake inhibitors - pharmacology (766) 766
psychiatry (715) 715
adult (594) 594
adrenergic uptake inhibitors - therapeutic use (586) 586
dose-response relationship, drug (549) 549
rats, sprague-dawley (541) 541
middle aged (455) 455
adrenergic uptake inhibitors - administration & dosage (430) 430
mice (418) 418
treatment outcome (405) 405
norepinephrine (400) 400
norepinephrine - metabolism (348) 348
rats, wistar (340) 340
atomoxetine hydrochloride (331) 331
attention deficit disorder with hyperactivity - drug therapy (326) 326
drug therapy (324) 324
adrenergic uptake inhibitors - adverse effects (318) 318
noradrenaline (317) 317
serotonin (317) 317
adolescent (316) 316
dopamine (314) 314
serotonin uptake inhibitors - pharmacology (311) 311
time factors (310) 310
double-blind (309) 309
clinical neurology (306) 306
physiology (298) 298
antidepressants (286) 286
child (275) 275
medicine & public health (271) 271
research (268) 268
double-blind method (265) 265
aged (264) 264
atomoxetine (256) 256
cardiac & cardiovascular systems (247) 247
serotonin uptake inhibitors - therapeutic use (247) 247
article (241) 241
adrenergic beta-antagonists - therapeutic use (240) 240
disease models, animal (216) 216
depression (214) 214
drug interactions (214) 214
pharmacology/toxicology (214) 214
adrenergic beta-antagonists - pharmacology (213) 213
brain (210) 210
propylamines - therapeutic use (209) 209
receptors (208) 208
care and treatment (205) 205
adrenergic alpha-antagonists - pharmacology (200) 200
analysis (200) 200
biomedicine (200) 200
rodents (200) 200
neurology (197) 197
rat (191) 191
antidepressive agents - pharmacology (189) 189
adhd (187) 187
attention-deficit hyperactivity disorder (187) 187
children (187) 187
physiological aspects (187) 187
heart failure (185) 185
pharmacology (184) 184
adrenergic receptors (182) 182
desipramine - pharmacology (181) 181
in vitro techniques (180) 180
in-vivo (177) 177
drug administration schedule (174) 174
behavior, animal - drug effects (173) 173
methylphenidate (171) 171
biochemistry & molecular biology (170) 170
blood pressure - drug effects (170) 170
deficit hyperactivity disorder (170) 170
brain - drug effects (165) 165
dopamine - metabolism (165) 165
heart rate - drug effects (165) 165
attention deficit hyperactivity disorder (164) 164
attention-deficit/hyperactivity disorder (164) 164
pediatrics (161) 161
prefrontal cortex (161) 161
adrenergic alpha-agonists - pharmacology (160) 160
brain - metabolism (158) 158
adrenergic beta-agonists - pharmacology (156) 156
metabolism (156) 156
health aspects (155) 155
rat-brain (151) 151
neurons (150) 150
serotonin - metabolism (147) 147
young adult (145) 145
dosage and administration (144) 144
motor activity - drug effects (144) 144
drugs (143) 143
antidepressive agents - therapeutic use (142) 142
cardiology (142) 142
microdialysis (142) 142
drug therapy, combination (140) 140
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3804) 3804
Japanese (30) 30
German (20) 20
Russian (12) 12
French (6) 6
Spanish (5) 5
Arabic (2) 2
Norwegian (2) 2
Chinese (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Italian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurology, ISSN 0028-3878, 04/2012, Volume 78, Issue 16, pp. 1229 - 1236
Journal Article
Regional Anesthesia and Pain Medicine, ISSN 1098-7339, 05/2010, Volume 35, Issue 3, pp. 294 - 303
Duloxetine is a serotonin and norepinephrine reuptake inhibitor that possesses antidepressant and pain-relieving properties. Compared with other... 
COMPARING DULOXETINE | SEROTONIN SYNDROME | NOREPINEPHRINE REUPTAKE INHIBITOR | FIBROMYALGIA FIBROSITIS SYNDROME | HEPATIC SAFETY PROFILE | DOUBLE-BLIND | ANESTHESIOLOGY | MAJOR DEPRESSIVE DISORDER | PERIPHERAL NEUROPATHIC PAIN | RANDOMIZED CONTROLLED-TRIAL | DIABETIC-NEUROPATHY | Serotonin Uptake Inhibitors - pharmacokinetics | Thiophenes - therapeutic use | Analgesics, Non-Narcotic - pharmacokinetics | Thiophenes - adverse effects | Humans | Analgesics, Non-Narcotic - pharmacology | Parkinson Disease - drug therapy | Thiophenes - administration & dosage | Osteoarthritis - drug therapy | Pain - drug therapy | Analgesics, Non-Narcotic - adverse effects | Antidepressive Agents - pharmacology | Thiophenes - economics | Analgesics, Non-Narcotic - economics | Adrenergic Uptake Inhibitors - economics | Adrenergic Uptake Inhibitors - adverse effects | Headache - drug therapy | Adrenergic Uptake Inhibitors - therapeutic use | Adrenergic Uptake Inhibitors - pharmacokinetics | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Thiophenes - pharmacology | Analgesics, Non-Narcotic - administration & dosage | Serotonin Uptake Inhibitors - economics | Analgesics, Non-Narcotic - therapeutic use | Neuralgia - drug therapy | Randomized Controlled Trials as Topic | Antidepressive Agents - therapeutic use | Thiophenes - pharmacokinetics | Serotonin Uptake Inhibitors - administration & dosage | Cost-Benefit Analysis | Adrenergic Uptake Inhibitors - administration & dosage | Antidepressive Agents - economics | Duloxetine Hydrochloride | Adrenergic Uptake Inhibitors - pharmacology | Antidepressive Agents - administration & dosage | Antidepressive Agents - adverse effects | Antidepressive Agents - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacology | Chronic Disease | Care and treatment | Pain | Parkinson's disease | Analgesics | Depression, Mental | Fibromyalgia | Osteoarthritis | Chronic pain | Antidepressants, Tricyclic
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 5/2011, Volume 50, Issue 5, pp. 281 - 294
Journal Article
Neurology, ISSN 0028-3878, 10/2006, Volume 67, Issue 8, pp. 1411 - 1420
Background: Serotonin (5-HT) and norepinephrine (NE) are involved in pain modulation via descending inhibitory pathways in the brain and spinal cord.... 
NOREPINEPHRINE REUPTAKE INHIBITOR | EFFICACY | PERSISTENT PAIN | DOUBLE-BLIND | MAJOR DEPRESSIVE DISORDER | PLACEBO-CONTROLLED TRIAL | EXTENDED-RELEASE | CLINICAL NEUROLOGY | IMIPRAMINE TREATMENT | DUAL-SEROTONIN | VENLAFAXINE | Diabetic Neuropathies - blood | Thiophenes - therapeutic use | Humans | Middle Aged | Acetaminophen - administration & dosage | Male | Palliative Care | Peripheral Nervous System Diseases - physiopathology | Thiophenes - administration & dosage | Thiophenes - blood | Peripheral Nervous System Diseases - blood | Female | Serotonin Uptake Inhibitors - blood | Adrenergic Uptake Inhibitors - blood | Acetaminophen - therapeutic use | Neuralgia - physiopathology | Drug Therapy, Combination | Diabetic Neuropathies - physiopathology | Severity of Illness Index | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Drug Administration Schedule | Serotonin Uptake Inhibitors - therapeutic use | Treatment Outcome | Analgesics, Non-Narcotic - administration & dosage | Diabetic Neuropathies - drug therapy | Analgesics, Non-Narcotic - therapeutic use | Neuralgia - drug therapy | Norepinephrine - metabolism | Neuralgia - blood | Serotonin Uptake Inhibitors - administration & dosage | Pain - physiopathology | Adrenergic Uptake Inhibitors - administration & dosage | Duloxetine Hydrochloride | Aged | Peripheral Nervous System Diseases - drug therapy
Journal Article
Science, ISSN 0036-8075, 9/2010, Volume 329, Issue 5998, pp. 1537 - 1541
The serotonin transporter (SERT) ensures the recapture of serotonin and is the pharmacological target of selective serotonin reuptake inhibitor (SSRI)... 
Receptors | MicroRNA | Serotonin agents | Neurons | Antidepressants | Serotonin receptors | REPORTS | Cell lines | Serotonin plasma membrane transport proteins | Adrenergic neurons | Locus coeruleus | LOCUS-COERULEUS | CELLS | RECEPTOR | RECOGNITION | RAT | MULTIDISCIPLINARY SCIENCES | Up-Regulation | Protein Biosynthesis | Humans | MicroRNAs - metabolism | Nerve Growth Factors - metabolism | Antidepressive Agents, Second-Generation - administration & dosage | Raphe Nuclei - metabolism | Serotonin Plasma Membrane Transport Proteins - genetics | Neurons - metabolism | 3' Untranslated Regions | Neurons - drug effects | Serotonin Uptake Inhibitors - metabolism | Cell Line | Fluoxetine - pharmacology | S100 Calcium Binding Protein beta Subunit | MicroRNAs - administration & dosage | Depression | S100 Proteins - metabolism | Antidepressive Agents, Second-Generation - pharmacology | Serotonin Plasma Membrane Transport Proteins - metabolism | Animals | Norepinephrine - metabolism | Raphe Nuclei - drug effects | Serotonin Uptake Inhibitors - administration & dosage | Serotonin - metabolism | Fluoxetine - administration & dosage | Fluoxetine - metabolism | Mice | MicroRNAs - genetics | HeLa Cells | Antidepressive Agents, Second-Generation - metabolism | Serotonin Uptake Inhibitors - pharmacology | Locus Coeruleus - metabolism | Pharmacogenetics | Serotonin | Physiological aspects | Serotonin uptake inhibitors | Dosage and administration | Research | Health aspects | Pharmacology
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 12/2018, Volume 32, Issue 12, pp. 1351 - 1361
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 07/2010, Volume 114, Issue 1, pp. 259 - 270
J. Neurochem. (2010) 114, 259–270. Acute administration of atomoxetine and methylphenidate, attention‐deficit/hyperactivity disorder (ADHD) drugs, activates... 
methylphenidate | striatum | atomoxetine | dopamine | mice | prefrontal cortex | Striatum | Mice | Dopamine | Prefrontal cortex | Atomoxetine | Methylphenidate | SUBSTANCE-ABUSE | DEFICIT HYPERACTIVITY DISORDER | FIRING PATTERN | BIOCHEMISTRY & MOLECULAR BIOLOGY | FRONTAL-CORTEX | REPEATED METHAMPHETAMINE | NEUROSCIENCES | VENTRAL TEGMENTAL AREA | NUCLEUS-ACCUMBENS | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | WORKING-MEMORY PERFORMANCE | FREELY-MOVING RATS | Motor Activity - drug effects | Male | Corpus Striatum - metabolism | Extracellular Space - metabolism | Prefrontal Cortex - drug effects | Atomoxetine Hydrochloride | Neurons - metabolism | Dopamine - metabolism | Methylphenidate - administration & dosage | Dopamine Uptake Inhibitors - pharmacology | Proto-Oncogene Proteins c-fos - metabolism | Methylphenidate - pharmacology | Mice, Inbred ICR | Dopamine Uptake Inhibitors - administration & dosage | Animals | Microdialysis | Norepinephrine - metabolism | Propylamines - administration & dosage | Serotonin - metabolism | Prefrontal Cortex - metabolism | Adrenergic Uptake Inhibitors - administration & dosage | Corpus Striatum - drug effects | Adrenergic Uptake Inhibitors - pharmacology | Propylamines - pharmacology | Biogenic Monoamines - metabolism | Child development | Serotonin | Neurons | Analysis | Phenols | Universities and colleges | Methylphenidate hydrochloride | Noradrenaline | Brain | Adrenal glands | Rodents | Cells
Journal Article
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 02/2014, Volume 34, Issue 1, pp. 47 - 56
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2009, Volume 52, Issue 21, pp. 6768 - 6781
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 2015, Volume 309, Issue 11, pp. H1904 - H1914
Perivascular adipose tissue (PVAT) reduces vasoconstriction to norepinephrine (NE). A mechanism by which PVAT could function to reduce vascular contraction is... 
Catecholamines | Perivascular adipose tissue | Adipocytes | High-performance liquid chromotography | Norepinephrine uptake | 4-[4-(dimethylamino)-styrl]-N-methylpyridinium iodide | perivascular adipose tissue | catecholamines | NEUROTRANSMITTER TRANSPORTERS | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | NORADRENALINE RELEASE | RAT | high-performance liquid chromotography | BLOOD-PRESSURE | HYPERTENSION EPIDEMIOLOGY | INSULIN-RESISTANCE | VASCULAR FUNCTION | FAT | PERIPHERAL VASCULAR DISEASE | norepinephrine uptake | SEROTONIN | adipocytes | REAL-TIME | Immunohistochemistry | Organic Anion Transporters, Sodium-Independent - genetics | Corticosterone - pharmacology | Organic Anion Transporters, Sodium-Independent - antagonists & inhibitors | Male | Adipocytes - drug effects | Chromatography, High Pressure Liquid | RNA, Messenger - metabolism | Biological Transport | Organic Anion Transporters, Sodium-Independent - metabolism | Intra-Abdominal Fat - drug effects | Real-Time Polymerase Chain Reaction | RNA-Binding Proteins - antagonists & inhibitors | Norepinephrine Plasma Membrane Transport Proteins - antagonists & inhibitors | Intra-Abdominal Fat - metabolism | Rats, Sprague-Dawley | Aorta, Thoracic | Microscopy, Confocal | Animals | Norepinephrine - metabolism | Adipocytes - metabolism | Mesenteric Arteries | Adrenergic Uptake Inhibitors - pharmacology | Norepinephrine Plasma Membrane Transport Proteins - metabolism | RNA-Binding Proteins - metabolism | Adipose tissues | Corticosterone | Antidepressants | Dosage and administration | Observations | Health aspects | Noradrenaline | Biological transport, Active | Vascular Biology and Microcirculation
Journal Article